We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Comprehensive Study of COVID-19 Detection Tools and Technologies to Help Develop Low-Cost Device for Use by Anyone, Anywhere

By LabMedica International staff writers
Posted on 17 Jun 2021
A team of researchers has sifted through hundreds of research papers for determining the COVID-19 detection tools and technologies that best detect the virus in order to help develop a low-cost device for use by anyone, anywhere.

A team of researchers led by engineers at Concordia University (Montreal, Canada) have combed the growing pile of literature on COVID-19 tools and techniques. More...
Clinical research on COVID-19 has boomed in the 18 months since the disease first appeared. Countless papers have looked at the topic from almost every possible angle, including methods of detection. The team wanted to categorize and understand what exists, what is lacking and what can be improved. The result was a thorough assessment of the field citing almost 600 separate papers that cover an extensive body of literature. The researchers believe that their new paper published in the journal Clinical Microbiology Reviews provides a rich “one-stop shop” resource for people interested in the topic, including experts in clinical microbiology and non-experts who want to know more about different methods.

The researchers point out that the explosion of detection techniques and tools - some of questionable quality - came from the need to expand testing rapidly while supply chains were disrupted by the virus’s global spread. Some techniques are more accurate; others are more affordable. Some require sophisticated lab equipment; others do not. The World Health Organization’s internationally recognized ASSURED criteria for point-of-care diagnostic devices helped them assess the various tests being used. The acronym stands for affordable, sensitive, specific, user-friendly, rapid and robust, equipment-free and deliverable to end users. This helped the researchers determine the strengths and weaknesses of the existing diagnostic tools.

According to the researchers, the most effective tools in use now are nucleic acid amplification tests, which are highly effective at detecting ribonucleic acid (RNA). The researchers hope that identifying current weaknesses in our diagnostic tools will help avoid the need of adopting drastic measures like lockdowns and shuttering the economy when the next pandemic emerges.

“Our study looks at these technologies’ performance characteristics, their challenges and the gaps in our current knowledge and future directions,” said the study’s primary investigator and lead author Hamid Tali, a PhD student in the Department of Chemical and Materials Engineering. “We describe the lessons learned throughout the pandemic on the diagnostics of this virus, which will be helpful in the case of a future pandemic. We hope that this will help guide researchers toward an ideal device that can be used by anyone, anywhere at a very low cost.”

Related Links:
Concordia University


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Host Response Immunoassay Test
MeMed BV
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.